[Prognostic experiences in the long-term differential therapy of chronic aggressive hepatitides].
D000293:Adolescent; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D002648:Child; D002908:Chronic Disease; D005260:Female; D006505:Hepatitis / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D007501:Iron / Q000097:blood; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011379:Prognosis; D013448:Sulfobromophthalein; D013997:Time Factors; D000637:Transaminases / Q000097:blood
D013448:Sulfobromophthalein; D011239:Prednisolone; D007501:Iron; D000637:Transaminases; D000469:Alkaline Phosphatase
Prognostische Erfahrungen in der Langzeit-Differentialtherapie chronisch-aggressiver Hepatitiden